DUBLIN, Ireland, March 22, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical ...
Dar es Salaam. Health practitioners in Tanzania are optimistic after the official registration of Lenacapavir, a long-acting ...
New HIV studies presented this week at the Conference on Retroviruses and Opportunistic Infections (CROI 2026) highlight critical evidence gaps that must be addressed to improve HIV treatment ...
Phase 3 trial results show BIC/LEN is noninferior to BIC/FTC/TAF for maintaining virologic suppression in adults with HIV.
Dar es Salaam. Tanzania has officially registered Lenacapavir, a long-acting injectable drug for the prevention and control of HIV, marking what officials describe as a significant milestone in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results